BSE
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Company News Details
Strides Pharma Science Ltd Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
532531
ISIN Demat
INE939A01011
Book Value (Rs)
356.2353295
NSE Symbol
STAR
Divident Yield %
0.42
Market Cap
(Rs In Cr.)
11,086
P/E (TTM)
61.55
EPS (TTM)
19.54
Face Value
(Rs)
10
Back
Strides Pharma Science consolidated net profit rises 54.45% in the March 2026 quarter
18-May-26   Hrs IST

Net profit of Strides Pharma Science rose 54.45% to Rs 126.94 crore in the quarter ended March 2026 as against Rs 82.19 crore during the previous quarter ended March 2025. Sales rose 11.18% to Rs 1323.47 crore in the quarter ended March 2026 as against Rs 1190.39 crore during the previous quarter ended March 2025.

For the full year,net profit declined 84.52% to Rs 556.19 crore in the year ended March 2026 as against Rs 3593.46 crore during the previous year ended March 2025. Sales rose 6.43% to Rs 4858.68 crore in the year ended March 2026 as against Rs 4565.34 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales1323.471190.39 11 4858.684565.34 6
OPM %18.1118.30 -19.0417.58 -
PBDT207.71182.66 14 897.93614.52 46
PBT154.46133.80 15 695.53422.26 65
NP126.9482.19 54 556.193593.46 -85

Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, Developed , Maintained and Content Powered by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)